Trius Therapeutics Initiates Phase 3 Program of Oral Torezolid Phosphate for the Treatment of ABSSSI
8/30/2010 8:09:06 AM
More...
|
Trius Therapeutics Reports 2010 Second Quarter Results
8/20/2010 10:09:51 AM
More...
|
Trius Therapeutics Decreases Size of IPO Deal from $78M to $49M
8/3/2010 7:17:55 AM
More...
|
Trius Therapeutics Set to go Public This Week
7/28/2010 7:22:00 AM
More...
|
Trius Therapeutics IPO Plans Back on Track
7/22/2010 7:36:06 AM
More...
|
Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
6/16/2010 10:48:26 AM
More...
|
Trius Therapeutics Awarded U.S. Department of Defense Contract to Develop Novel Antibiotics
5/19/2010 9:38:50 AM
More...
|
Trius Therapeutics Announces Results From Phase 1 Clinical Trial of Intravenous Torezolid Phosphate
3/30/2010 10:33:04 AM
More...
|
Trius Therapeutics to Conform Protocol for Upcoming Torezolid Phosphate Phase 3 Trial With Newly Released FDA Draft Guidance
3/1/2010 11:28:13 AM
More...
|
Trius Therapeutics Files for IPO
11/9/2009 8:07:29 AM
More...
|
|